"Skip to main content
Search Login Content About Publish NEWS 06 January 2022 WHO chief Tedros looks guaranteed for re-election amid COVID pandemic Tedros Adhanom Ghebreyesus is the only nominee to head the World Health Organization, a possible nod from countries on their approval of his pandemic leadership. Amy Maxmen Twitter Facebook Email
Tedros Adhanom Ghebreyesus is the only candidate who will run for WHO director-general in May.Credit: Fabrice Coffrini/AFP/Getty
Tedros Adhanom Ghebreyesus, the director-general of the World Health Organization (WHO), is all but ensured to lead the organization for a second term, from 2022 to 2027, because he is the only candidate in the race. As a matter of procedure, on 25 January, the WHO’s executive board is expected to nominate him for re-election in May.
The probable extension of his leadership occurs against the backdrop of the ongoing COVID-19 pandemic, as the health agency continues to advise countries on how to curb the coronavirus’s devastation.
Why did the world’s pandemic warning system fail when COVID hit?
This isn’t the first time a WHO director-general has run for a second term unopposed. Typically, however, several countries propose candidates in the year before an election. Elections are held every five years at the World Health Assembly in May, an annual meeting of delegates from WHO member states. This year, Tedros is the only nominee, with 28 member states, including several European countries and 3 African nations, backing him.
“It is my government’s deep belief that Dr. Tedros, the current Director-General of the WHO, is ideally placed to continue,” wrote Kenya’s cabinet secretary Mutahi Kagwe in a nomination letter.
China, the United States and about 160 other countries did not nominate anyone. This could be a modest vote of confidence in Tedros, an acknowledgement that a competitor would not prevail, or a matter of pandemic practicality, global-health researchers tell Nature. Amanda Glassman, executive vice-president at the Center for Global Development in Washington DC, says, “Generally, you don’t want to change leadership in a war.”
At the helm Up against five candidates, Tedros won the election for director-general in 2017, becoming the first African to lead the WHO since its founding in 1948. He quickly made his mark by creating the WHO’s first science division, and by expanding its programme to respond to infectious-disease outbreaks and other health emergencies. These reforms were tested almost immediately by an Ebola outbreak in a conflict-ridden region of the Democratic Republic of the Congo in 2018, where the WHO responded on the ground for two years and helped to organize studies to test a new Ebola vaccine and treatments for the disease.
Exclusive: Behind the front lines of the Ebola wars
That outbreak was ongoing when China reported what turned out to be COVID-19 in December 2019. During the years that have followed, Tedros has won admirers among the global-health community. “He has spoken in stark terms about the need for countries to pursue a more equitable approach to vaccine distribution,” says Tom Bollyky, director of global health at the Council on Foreign Relations in Washington DC. Last month, researchers applauded Tedros for helping to persuade the WHO’s 194 member states to move ahead with plans for a pandemic accord, which would dictate how countries respond to future outbreaks.
He has also promised to reform the organization — an action that government leaders and global-health researchers called for after evaluating the WHO’s performance during this pandemic. “Our job is not yet done,” Tedros wrote in a statement expressing his wish for re-election. “After witnessing up close the world’s response to the pandemic, I have a unique understanding of the dynamics that have brought us to where we are.”
Staying the course That Tedros would be embraced as a second-term leader was not a given. In the first year of the pandemic, some researchers decried the WHO’s delayed public warning that the SARS-CoV-2 coronavirus could spread through the air, and several leaders faulted the WHO for not being tougher with China for its lack of transparency in reporting early COVID-19 cases and in cooperating with COVID-19 origin investigations. This culminated in May 2020, when former US president Donald Trump announced that the United States would withdraw from the organization because of its alleged leniency with China. (US membership was reinstated by US President Joe Biden last year.) Meanwhile, Chinese officials voiced discontent with Tedros last year, after he said that China should permit a deeper investigation into the origins of SARS-CoV-2, including the possibility that it leaked from a lab there.
World commits to a pandemic-response pact: what’s next
Despite the discontent, neither the United States nor China presented a challenger to Tedros’ leadership. One possible reason, Bollyky suggests, is that world leaders understand the limited tools at the disposal of WHO directors. The agency has little power to enforce its recommendations, and sharply criticizing powerful member states has proven ineffective. An example of this limited control was showcased last year. Tedros repeatedly asked wealthy nations to support vaccine equity by donating doses, sharing COVID-19 vaccine patents and delaying booster shots until health workers around the world could get inoculated. Those pleas have largely been ignored.
A related possibility, Glassman says, is that the role seems exceedingly difficult. “I guess there aren’t a lot of candidates clamouring to take this job at this stage in the pandemic,” she says.
What is unusual about Tedros’ second-term candidacy is that his home country, Ethiopia, didn’t nominate him. Researchers suggest that could be due to Tedros bemoaning the worsening conflict between the Ethiopian government and people in the country’s northern Tigray region, where he is from. “I worry about my country,” he said at a WHO press briefing on 28 December. “I have many relatives there, including my younger brother, and I don’t know where they are.”
Nonetheless, Tedros is the first candidate in the WHO’s history to be nominated by more than two dozen countries, which speaks to his popularity — or perhaps to the world’s desire for steady leadership. “During a pandemic, it would be difficult to think about changing the director-general,” says Youngmee Jee, chief executive at the Pasteur Institute in Seongnam, South Korea.
doi: https://doi.org/10.1038/d41586-022-00019-4
Related Articles World commits to a pandemic-response pact: what’s next Why did the world’s pandemic warning system fail when COVID hit? What a US exit from the WHO means for COVID-19 and global health Exclusive: Behind the front lines of the Ebola wars World Health Organization gets first leader from Africa Subjects Public health SARS-CoV-2 Government Politics Latest on: Public health SARS-CoV-2 Government
Researchers fear growing COVID vaccine hesitancy in developing nations NEWS 23 DEC 21
Half measures in One Health fail people and the environment CORRESPONDENCE 21 DEC 21
How COVID vaccines shaped 2021 in eight powerful charts NEWS 16 DEC 21
Jobs Faculty Positions The Hong Kong University of Science and Technology
Guangzhou, China
Institute Director/ Professor in Synthetic Biology The Hong Kong University of Science and Technology
Hong Kong, China
Postdoctoral Scientist Peter MacCallum Cancer Centre (Peter Mac)
Melbourne, Australia
Doctoral Candidate (PhD) in Computer Science on Decentralised Markets for Digital Assets Interdisciplinary Centre for Security, Reliability and Trust (SnT), University of Luxembourg
Luxembourg, Luxembourg
Close Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing Nature (Nature) ISSN 1476-4687 (online) ISSN 0028-0836 (print)
nature.com sitemap
About us Press releases Press office Contact us Discover content Journals A-Z Articles by subject Nano Protocol Exchange Nature Index Publishing policies Nature portfolio policies Open access Author & Researcher services Reprints & permissions Research data Language editing Scientific editing Nature Masterclasses Nature Research Academies Libraries & institutions Librarian service & tools Librarian portal Open research Recommend to library Advertising & partnerships Advertising Partnerships & Services Media kits Branded content Career development Nature Careers Nature Conferences Nature events Regional websites Nature Africa Nature China Nature India Nature Italy Nature Japan Nature Korea Nature Middle East Legal & Privacy Privacy Policy Use of cookies Manage cookies/Do not sell my data Legal notice Accessibility statement Terms & Conditions California Privacy Statement
© 2022 Springer Nature Limited" https://www.nature.com/articles/d41586-022-00019-4#:~:text=Skip%20to%20main,Springer%20Nature%20Limited
0 nhận xét:
Đăng nhận xét